TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,333,116 | -39.6% | 95,074 | -0.1% | 1.36% | -43.0% |
| Q1 2023 | $3,864,245 | +490.0% | 95,155 | +553.0% | 2.38% | +464.9% |
| Q4 2022 | $654,966 | -8.7% | 14,571 | -2.8% | 0.42% | -18.2% |
| Q3 2022 | $717,000 | -19.5% | 14,993 | -0.4% | 0.52% | -11.9% |
| Q2 2022 | $891,000 | -26.1% | 15,053 | +45.1% | 0.59% | -8.3% |
| Q1 2022 | $1,206,000 | -23.6% | 10,372 | -1.2% | 0.64% | -17.9% |
| Q4 2021 | $1,579,000 | +26.0% | 10,493 | -0.0% | 0.78% | +22.7% |
| Q3 2021 | $1,253,000 | +20.6% | 10,498 | -1.5% | 0.63% | +19.4% |
| Q2 2021 | $1,039,000 | -44.8% | 10,663 | -50.0% | 0.53% | -1.8% |
| Q1 2021 | $1,882,000 | +94.8% | 21,326 | +111.3% | 0.54% | -2.9% |
| Q4 2020 | $966,000 | -15.7% | 10,094 | 0.0% | 0.56% | -35.1% |
| Q3 2020 | $1,146,000 | +22.6% | 10,094 | +6.8% | 0.86% | +7.1% |
| Q2 2020 | $935,000 | +53.3% | 9,448 | -0.3% | 0.80% | +9.7% |
| Q1 2020 | $610,000 | – | 9,478 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
| Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
| Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
| Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
| SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
| FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
| Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
| OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
| First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |